ImmunoCovid - Coronavirus infections in primary or secondary immunosuppressed Children
Summary
This is an observational study to investigate the impact of Covid-19 on children who are immunosuppressed. The study is designed to allow a parent of immunosuppressed children and the children and teenagers to self-record their experiences each week via a website link.
This study is complementary to the ISARIC/WHO study, also available for children to participate in.
Priority
This is a study which is considered a national priority.
Treatment
As an observational study, treatment will be standard care.
Who can participate?
Patients will be eligible if they are
- Parent of an immunosuppressed patient aged less than 16 years, or immunosuppressed patients aged 16-17 years.
- +ve Covid Diagnosis
- Family able to complete the questionnaire which will be in English
- Reliable access to the internet
